TRI — TrivarX Income Statement
0.000.00%
- AU$5.58m
- AU$4.97m
- AU$0.89m
- 35
- 82
- 34
- 51
Annual income statement for TrivarX, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.933 | 1.27 | 1.01 | 0.96 | 0.893 |
Cost of Revenue | |||||
Gross Profit | 0.728 | 1.1 | 1.01 | 0.96 | 0.893 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 4.77 | 2.74 | 13.7 | 4.02 | 2.31 |
Operating Profit | -3.84 | -1.47 | -12.7 | -3.06 | -1.42 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -3.87 | -1.49 | -12.7 | -3.07 | -1.43 |
Provision for Income Taxes | |||||
Net Income After Taxes | -3.87 | -1.49 | -12.7 | -3.07 | -1.43 |
Net Income Before Extraordinary Items | |||||
Net Income | -3.87 | -1.49 | -12.7 | -3.07 | -1.43 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -3.87 | -1.49 | -12.7 | -3.07 | -1.43 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.079 | -0.019 | -0.026 | -0.01 | -0.004 |